Tip 1 Diyabetli Çocuklarda Lipohipertrofi Sıklığı ve Risk Faktörlerinin İncelenmesi
Yükleniyor...
Tarih
2018
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Ortadoğu Reklam Tanitim Yayincilik Turizm Egitim Insaat Sanayi ve Ticaret
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Tip 1 diyabetli bireylerde önerilen ilaç tedavisi insülindir. İnsülin tedavisinin komplikasyonlarından biri de lipohipertrofidir. Tip 1 diyabetli çocuklarda lipohipertrofi sıklığı ve risk faktörlerinin incelenmesidir. Gereç ve Yöntemler: Tanımlayıcı kesitsel araştırma tasarımı kullanılmıştır. Araştırma Haziran-Ekim 2017 tarihleri arasında; Türkiye'de bir Çocuk Hastanesinin Diyabet Eğitim ve İzlem Merkezi'nde yürütülmüştür. Veri toplamak için tanıtıcı bilgiler formu kullanılmıştır. Çalışmanın yapılacağı kurumlardan izin ve etik kurulundan etik onay alınmıştır. Araştırma sonucunda, elde edilen veriler değerlendirilirken sayı, yüzde ve ki-kare analizi kullanılmıştır. Bulgular: Bu çalışmada hastaların %61,1'inde lipohipertrofi olduğu belirlenmiş ve belirlenen lipohipertrofinin %73,61'i en fazla kollarda görülürken, takiben %18,5'inin karın bölgesinde olduğu saptanmıştır. Bununla birlikte lipohipertrofi gelişimini etkileyen faktörler olarak hastaların diyabet tanı süresi, diyabet tedavi süresi ve alan rotasyonun önemli faktörler olduğu belirlenmiştir. Sonuç: Bu çalışmada Tip 1 diyabetli çocuklarda lipohipertrofi görülme sıklığının azımsanmayacak oranlarda olduğu ve lipohipertrofinin en fazla kollarda görüldüğü belirlenmiştir. Bunun yanı sıra, Tip 1 diyabetli çocuklarda diyabet hemşirelerinin insülin eğitiminde; diyabet tanı süresi, insülin tedavi süresi ve alan rotasyonu konusunda özellikle dikkat etmeleri gerektiği bulunmuştur. Lipohipertrofi gelişiminin nasıl önlenebileceğiyle ilgili randomize kontrollü girişimsel çalışmaların yapılması önerilmektedir.
Objective: Drug therapy recommended for people with Type 1 diabetes is insulin. One of the complications of insulins medication is lipohypertrophy. The aim of this study was to analyze the frequency and risk factors of lipohypertrophy in the children with Type 1 diabetes. Material and Methods: A descriptive cross sectional study design was used. The study was conducted between June-October 2017 in a Diabetes Education and Monitoring Center in a Children's Hospital in Turkey. A descriptive information form was used to collect the data. Ethical approval and permission were obtained from the ethics committee and the institution, respectively. As a result of the study, number, percentage and chi-square analysis were used to evaluate the data. Results: In this study, 61.1% of the patients were found to have lipohipthrophy, and it was determined that lipohipertrophy was mostly found in arms (73.61%), arms were followed by abdominal region, its incidence was 18.5% in the abdominal region. However, it was determined that the duration of diabetes diagnosis, duration of diabetes treatment and field rotation were significant factors which affect the development of lipohipertrophy. Conclusion: In this study, it was determined that the incidence of lipohypertrophy in the children with Type 1 diabetes is substantial, lipohipertrophy was mostly observed in eyes. In addition, in children with Type 1 diabetes, diabet nurses should be careful about the duration of diabetes diagnosis, duration of insulin treatment and field rotation. It is recommended to perform randomized controlled interventional studies on how to prevent the development of lipohypertrophy.
Objective: Drug therapy recommended for people with Type 1 diabetes is insulin. One of the complications of insulins medication is lipohypertrophy. The aim of this study was to analyze the frequency and risk factors of lipohypertrophy in the children with Type 1 diabetes. Material and Methods: A descriptive cross sectional study design was used. The study was conducted between June-October 2017 in a Diabetes Education and Monitoring Center in a Children's Hospital in Turkey. A descriptive information form was used to collect the data. Ethical approval and permission were obtained from the ethics committee and the institution, respectively. As a result of the study, number, percentage and chi-square analysis were used to evaluate the data. Results: In this study, 61.1% of the patients were found to have lipohipthrophy, and it was determined that lipohipertrophy was mostly found in arms (73.61%), arms were followed by abdominal region, its incidence was 18.5% in the abdominal region. However, it was determined that the duration of diabetes diagnosis, duration of diabetes treatment and field rotation were significant factors which affect the development of lipohipertrophy. Conclusion: In this study, it was determined that the incidence of lipohypertrophy in the children with Type 1 diabetes is substantial, lipohipertrophy was mostly observed in eyes. In addition, in children with Type 1 diabetes, diabet nurses should be careful about the duration of diabetes diagnosis, duration of insulin treatment and field rotation. It is recommended to perform randomized controlled interventional studies on how to prevent the development of lipohypertrophy.
Açıklama
Anahtar Kelimeler
İğne, Tip 1 diyabet, Lipohipertrofi, Rotasyon, Needle, Type 1 diabetes, Lipohypertrophy, Rotation
Kaynak
Turkiye Klinikleri Pediatri
WoS Q Değeri
Scopus Q Değeri
Q4
Cilt
27
Sayı
2
Künye
Sürücü, H. A. ve Aydın, M. (2018). Tip 1 Diyabetli Çocuklarda Lipohipertrofi Sıklığı ve Risk Faktörlerinin İncelenmesi. Turkiye Klinikleri Pediatri, 27(2), 39-45.
